Cargando…
Epithelial‐mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine‐rich alpha‐2 glycoprotein
We previously showed that an inflammation‐related, molecule leucine‐rich alpha‐2 glycoprotein (LRG) enhances the transforming growth factor (TGF)‐β1‐induced phosphorylation of Smad proteins and is elevated in patients with pancreatic ductal adenocarcinoma (PDAC). As TGF‐β/Smad signaling is considere...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398893/ https://www.ncbi.nlm.nih.gov/pubmed/30575211 http://dx.doi.org/10.1111/cas.13918 |
_version_ | 1783399663494234112 |
---|---|
author | Otsuru, Toru Kobayashi, Shogo Wada, Hiroshi Takahashi, Tsuyoshi Gotoh, Kunihito Iwagami, Yoshifumi Yamada, Daisaku Noda, Takehiro Asaoka, Tadafumi Serada, Satoshi Fujimoto, Minoru Eguchi, Hidetoshi Mori, Masaki Doki, Yuichiro Naka, Testuji |
author_facet | Otsuru, Toru Kobayashi, Shogo Wada, Hiroshi Takahashi, Tsuyoshi Gotoh, Kunihito Iwagami, Yoshifumi Yamada, Daisaku Noda, Takehiro Asaoka, Tadafumi Serada, Satoshi Fujimoto, Minoru Eguchi, Hidetoshi Mori, Masaki Doki, Yuichiro Naka, Testuji |
author_sort | Otsuru, Toru |
collection | PubMed |
description | We previously showed that an inflammation‐related, molecule leucine‐rich alpha‐2 glycoprotein (LRG) enhances the transforming growth factor (TGF)‐β1‐induced phosphorylation of Smad proteins and is elevated in patients with pancreatic ductal adenocarcinoma (PDAC). As TGF‐β/Smad signaling is considered to play a key role in epithelial‐mesenchymal transition (EMT), we attempted to clarify the mechanism underlying LRG‐related EMT in relation to metastasis in PDAC. We cultured LRG‐overexpressing PDAC cells (Panc1/LRG) and evaluated the morphology, EMT‐related molecules and TGF‐β/Smad signaling pathway in these cells. We also assessed the LRG levels in plasma and resected specimens from patients with PDAC. Inflammatory cytokines induced LRG production in PDAC cells. A spindle‐like shape was visualized more frequently than other shapes in Panc1/LRG with TGF‐β1 exposure. The expression of E‐cadherin in Panc1/LRG was decreased with TGF‐β1 exposure. Invasion increased with TGF‐β1 stimulation of Panc1/LRG. The phosphorylation of smad2 in Panc1/LRG was increased in comparison with parental Panc1 under TGF‐β1 stimulation. In the plasma LRG‐high group, the recurrence rate tended to be higher and the recurrence‐free survival (RFS) tended to be worse in comparison with the plasma LRG‐low group. LRG enhanced EMT induced by TGF‐β signaling, thus indicating that LRG has a significant effect on the metastasis of PDAC. |
format | Online Article Text |
id | pubmed-6398893 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63988932019-03-14 Epithelial‐mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine‐rich alpha‐2 glycoprotein Otsuru, Toru Kobayashi, Shogo Wada, Hiroshi Takahashi, Tsuyoshi Gotoh, Kunihito Iwagami, Yoshifumi Yamada, Daisaku Noda, Takehiro Asaoka, Tadafumi Serada, Satoshi Fujimoto, Minoru Eguchi, Hidetoshi Mori, Masaki Doki, Yuichiro Naka, Testuji Cancer Sci Original Articles We previously showed that an inflammation‐related, molecule leucine‐rich alpha‐2 glycoprotein (LRG) enhances the transforming growth factor (TGF)‐β1‐induced phosphorylation of Smad proteins and is elevated in patients with pancreatic ductal adenocarcinoma (PDAC). As TGF‐β/Smad signaling is considered to play a key role in epithelial‐mesenchymal transition (EMT), we attempted to clarify the mechanism underlying LRG‐related EMT in relation to metastasis in PDAC. We cultured LRG‐overexpressing PDAC cells (Panc1/LRG) and evaluated the morphology, EMT‐related molecules and TGF‐β/Smad signaling pathway in these cells. We also assessed the LRG levels in plasma and resected specimens from patients with PDAC. Inflammatory cytokines induced LRG production in PDAC cells. A spindle‐like shape was visualized more frequently than other shapes in Panc1/LRG with TGF‐β1 exposure. The expression of E‐cadherin in Panc1/LRG was decreased with TGF‐β1 exposure. Invasion increased with TGF‐β1 stimulation of Panc1/LRG. The phosphorylation of smad2 in Panc1/LRG was increased in comparison with parental Panc1 under TGF‐β1 stimulation. In the plasma LRG‐high group, the recurrence rate tended to be higher and the recurrence‐free survival (RFS) tended to be worse in comparison with the plasma LRG‐low group. LRG enhanced EMT induced by TGF‐β signaling, thus indicating that LRG has a significant effect on the metastasis of PDAC. John Wiley and Sons Inc. 2019-02-04 2019-03 /pmc/articles/PMC6398893/ /pubmed/30575211 http://dx.doi.org/10.1111/cas.13918 Text en © 2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Otsuru, Toru Kobayashi, Shogo Wada, Hiroshi Takahashi, Tsuyoshi Gotoh, Kunihito Iwagami, Yoshifumi Yamada, Daisaku Noda, Takehiro Asaoka, Tadafumi Serada, Satoshi Fujimoto, Minoru Eguchi, Hidetoshi Mori, Masaki Doki, Yuichiro Naka, Testuji Epithelial‐mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine‐rich alpha‐2 glycoprotein |
title | Epithelial‐mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine‐rich alpha‐2 glycoprotein
|
title_full | Epithelial‐mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine‐rich alpha‐2 glycoprotein
|
title_fullStr | Epithelial‐mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine‐rich alpha‐2 glycoprotein
|
title_full_unstemmed | Epithelial‐mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine‐rich alpha‐2 glycoprotein
|
title_short | Epithelial‐mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine‐rich alpha‐2 glycoprotein
|
title_sort | epithelial‐mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine‐rich alpha‐2 glycoprotein |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398893/ https://www.ncbi.nlm.nih.gov/pubmed/30575211 http://dx.doi.org/10.1111/cas.13918 |
work_keys_str_mv | AT otsurutoru epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein AT kobayashishogo epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein AT wadahiroshi epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein AT takahashitsuyoshi epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein AT gotohkunihito epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein AT iwagamiyoshifumi epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein AT yamadadaisaku epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein AT nodatakehiro epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein AT asaokatadafumi epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein AT seradasatoshi epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein AT fujimotominoru epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein AT eguchihidetoshi epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein AT morimasaki epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein AT dokiyuichiro epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein AT nakatestuji epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein |